Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.
Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...
According to Mr. Lee Ming-Juan, Vice General Manager of Shine Out Bio Technology, preclinical studies using <ALPHA>DAT-EVs loaded with curcumin have demonstrated promising therapeutic effects in both ...
A growing body of research continues to reveal information about the Covid virus and its ability to cause harm long after ...
The American Cancer Society released its 2026 Facts & Figures, revealing that, for the first time ever, seven in ten cancer ...
Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...
UVA Health researchers are advancing a technology that may allow new vaccines to be designed, tested and distributed in weeks ...
Hundreds of millions of people are turning to chatbots to help figure out what's wrong with them. Doctors say that's not ...
The rapid evolutionary dynamics of RNA viruses, driven by high mutation rates and the consequent formation of complex ...
News Medical on MSN
Tracking antibiotic resistance across environmental systems using advanced metagenomic tools
Antibiotic resistance is often framed as a hospital problem, but a growing body of evidence shows that the environment plays ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results